BananaIP Counsels | Intellepedia

Robo Police Cars, Patents for Massaging Cows, Coolpad v. Xiaomi, Michelin’s design patent suit, EU fines Qualcomm, Qualcomm’s 2 billion dollar deal, Responding to First Examination Reports, Patent Tip of the Week and other Weekly Patent News.

This weekly update analyses patent statistics, key disputes, and licensing activities in India and globally. Highlights include recent inventions, design registrations, and practical tips on responding to examination reports, with an expert legal perspective.

Revocation of Patents in India – Lecture by Dr. Kalyan C. Kankanala at UPES School of Law

Dr. Kalyan C. Kankanala’s lecture at UPES School of Law covered the grounds and process for patent revocation in India, with a structured comparison to pre-grant and post-grant oppositions. The session offered objective insights into Indian patent law, supporting students in understanding critical legal concepts.

Post Grant Opposition of Patents in India – Lecture by Dr. Kalyan C. Kankanala at UPES School of Law

Dr. Kalyan C. Kankanala discusses post grant opposition of patents in India, focusing on the legal grounds and procedure under Section 25(2) of the Patent Act. The lecture was delivered as part of the Patent Law and Practice Program at UPES School of Law.

Pre Grant Opposition of Patents in India – Lecture by Dr. Kalyan C. Kankanala at UPES School of Law

Dr. Kalyan C. Kankanala discusses the pre grant opposition of patents in India, focusing on the legal provisions and grounds available under Section 25(1). The lecture highlights the importance of the opposition process in safeguarding patent quality.

Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala

This abridged Novartis case by Dr. Kalyan C. Kankanala explains the patentability requirements under Section 3(d) of Indian patent law. It provides a structured analysis of the legal and practical issues surrounding the Imatinib Mesylate patent application.

Another commendable initiative of Indian patent office – Publication of FER data in the journal

The Indian patent office now publishes FER issuance data weekly, making examination report details promptly accessible to applicants and agents. This initiative demonstrates the ongoing commitment to transparency and efficiency in patent administration.

Patents, Inventions, Inventors – Who really won the race? A peek into the Strategic Inventor Seminar by BananaIP Counsels

The Strategic Inventor Seminar by BananaIP Counsels provided corporate inventors with practical insights into patentability and infringement risks. Interactive sessions and expert guidance made it a valuable platform for knowledge sharing and networking.

BananaIP’s Patents for Inventors, Automatic Panipuri patent, Artificial heart patents, Qualcomm vs Apple, and more.

This weekly update presents key developments in Indian patent news, featuring patent office statistics, unique inventions, and major infringement cases. Noteworthy events and structured insights are included for inventors and IP professionals.

Restraint on Prasar Bharati, Why BananaIP? , Another suit against Spotify, Botox License and more

The post reviews major updates in copyright and entertainment law, focusing on Supreme Court decisions, new litigation, and licensing trends. Key topics include Prasar Bharati’s retransmission restrictions, lawsuits against Spotify, and recent music and patent licensing agreements.

Garbage patents, Smart Tiara’s, Language Patents, Unique seminar on patents, Qualcomm vs. Apple, Why the name BananaIP? Food recipies, Patent Tip of the Week and more.

This weekly update presents the latest in Indian patent news, including notable statistics, innovative patents, and legal developments. The post also highlights upcoming seminars and practical patent tips from BananaIP Counsels.